Skip to main content
. 2014 Jan-Feb;46(1):29–34. doi: 10.4103/0253-7613.125161

Table 3.

Adverse events occurring during 24 h preoperative infusion in levosimendan and control group

graphic file with name IJPharm-46-29-g004.jpg